Search research articles
Contact Us
Filters
Showing results (321-330 of 340) with videos related to
Page
of 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2023
CD24hiCD27+ Bregs within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer
Huanhuan Huang, Yao Yao, Lesang Shen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
February 23, 2022
SERPINA5 Protein in Cumulus-Oocyte Complexes Increases the Fertilisation Ability of Mouse Sperm
Siyuan Cao, Zhang Qian, Ronghua Wu, et al.
Plos One
|
January 26, 2013
Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers
Xianyu Zhang, Qian Sun, Ming Shan, et al.
International Journal of Oncology
|
June 2, 2023
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion
Yu Wang, Wenyu Guo, Zhaoqing Li, et al.
Cancer Letters
|
January 24, 2024
Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing
Fang Jia, Shanshan Sun, Jiaxin Li, et al.
International Journal of Oncology
|
March 21, 2025
[Retracted] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion
Yu Wang, Wenyu Guo, Zhaoqing Li, et al.
International Journal of Oncology
|
March 14, 2018
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
Yu Wang, Wenyu Guo, Zhaoqing Li, et al.
Cell Metabolism
|
May 13, 2026
Gut microbiota-derived deoxycholic acid shapes an immunosuppressive tumor microenvironment and promotes breast cancer progression
Lili Li, Chenghui Yang, Zhen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2018
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner
Shanshan Sun, Yansheng Wu, Wenyu Guo, et al.
Cancer Medicine
|
April 26, 2022
Treatment patterns, effectiveness, and patient-reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real-world study
Lesang Shen, Jun Zhou, Yiding Chen, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 340) with videos related to
Sort By:
Page
of 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2023
CD24hiCD27+ Bregs within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer
Huanhuan Huang, Yao Yao, Lesang Shen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
February 23, 2022
SERPINA5 Protein in Cumulus-Oocyte Complexes Increases the Fertilisation Ability of Mouse Sperm
Siyuan Cao, Zhang Qian, Ronghua Wu, et al.
Plos One
|
January 26, 2013
Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers
Xianyu Zhang, Qian Sun, Ming Shan, et al.
International Journal of Oncology
|
June 2, 2023
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion
Yu Wang, Wenyu Guo, Zhaoqing Li, et al.
Cancer Letters
|
January 24, 2024
Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing
Fang Jia, Shanshan Sun, Jiaxin Li, et al.
International Journal of Oncology
|
March 21, 2025
[Retracted] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion
Yu Wang, Wenyu Guo, Zhaoqing Li, et al.
International Journal of Oncology
|
March 14, 2018
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
Yu Wang, Wenyu Guo, Zhaoqing Li, et al.
Cell Metabolism
|
May 13, 2026
Gut microbiota-derived deoxycholic acid shapes an immunosuppressive tumor microenvironment and promotes breast cancer progression
Lili Li, Chenghui Yang, Zhen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2018
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner
Shanshan Sun, Yansheng Wu, Wenyu Guo, et al.
Cancer Medicine
|
April 26, 2022
Treatment patterns, effectiveness, and patient-reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real-world study
Lesang Shen, Jun Zhou, Yiding Chen, et al.
Page
of 34